ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 165 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $195,905 | +640.7% | 9,561 | +618.3% | 0.00% | – |
| Q2 2023 | $26,447 | +26.8% | 1,331 | +9.3% | 0.00% | – |
| Q1 2023 | $20,864 | -10.3% | 1,218 | +2.5% | 0.00% | – |
| Q4 2022 | $23,249 | +16.2% | 1,188 | -7.1% | 0.00% | – |
| Q3 2022 | $20,000 | -9.1% | 1,279 | -21.3% | 0.00% | – |
| Q2 2022 | $22,000 | -86.6% | 1,625 | -84.2% | 0.00% | – |
| Q1 2022 | $164,000 | -17.6% | 10,284 | +12.6% | 0.00% | – |
| Q4 2021 | $199,000 | -14.6% | 9,134 | +17.3% | 0.00% | – |
| Q3 2021 | $233,000 | -10.7% | 7,790 | +32.3% | 0.00% | – |
| Q2 2021 | $261,000 | +16.0% | 5,888 | +16.0% | 0.00% | – |
| Q1 2021 | $225,000 | +1507.1% | 5,077 | +1891.0% | 0.00% | – |
| Q4 2020 | $14,000 | +366.7% | 255 | +125.7% | 0.00% | – |
| Q3 2020 | $3,000 | – | 113 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 665,880 | $10,627,000 | 11.09% |
| RTW INVESTMENTS, LP | 15,802,802 | $252,213,000 | 5.82% |
| Ally Bridge Group (NY) LLC | 479,506 | $7,653,000 | 5.05% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,204,000 | 2.48% |
| TIGER MANAGEMENT L.L.C. | 279,700 | $4,464,000 | 1.95% |
| Prosight Management, LP | 200,000 | $3,192,000 | 1.71% |
| COWEN AND COMPANY, LLC | 999,588 | $15,953,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,398,000 | 1.32% |
| Affinity Asset Advisors, LLC | 267,794 | $4,274,000 | 1.19% |
| HARBOR CAPITAL ADVISORS, INC. | 66,410 | $1,060,000 | 0.97% |